Site Search
  • decreaseincrease
  • pdf

Washington Regional Introduces New, Minimally Invasive Aquablation Therapy for Patients with BPH

Washington Regional is the first health system in Northwest Arkansas to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) or enlarged prostate.

BPH is a non-cancerous condition where the prostate has grown to be larger than normal. Half of men ages 51 to 60 have BPH, and the incidence increases every decade of life. If left untreated, BPH can lead to significant health problems, including permanent bladder or kidney damage, bladder stones, and incontinence. Surgical treatments offer symptom relief but may lead to unwanted complications such as incontinence and sexual dysfunction. Aquablation therapy is a minimally invasive treatment that uses the power of water delivered with robotic precision to provide long-lasting symptom relief with low rates of irreversible complications.

“We are proud to be among the first in Arkansas to offer this option for men with BPH,” said Mark Jackson, MD, service chair of urology department at Washington Regional Medical Center. “Aquablation therapy uses a stream of water to remove prostate tissue and allows the urologist to map the prostate live during the procedure using both a camera and real time ultrasound mapping. This allows a defined amount of prostate tissue to be removed and leads to great outcomes. This system can also drastically cut down on surgical time, which means less time under an anesthetic for the patient.”

To learn more about who is a candidate for Aquablation therapy, click here.